A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Travis Lewis
Prevail Therapeutics, a Wholly Owned Subsidiary of Eli Lilly and Company
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ehime University Hospital
Tōon, Ehime, Japan
Not, yet, recruiting - Oita University Hospital
Yufu, Oita Prefecture, Japan
Not, yet, recruiting - P-One Clinic, Keikokai Medical Corporation
Hachiōji, Tokyo, Japan
Recruiting
- Austin Clinic Ppd
Austin, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Aug 2024
- Primary completion
- 5 May 2029
- Completion
- 5 May 2029
- Last update posted
- 18 May 2026
- Registered enrollment
- 124
- Registry id
- NCT06565195
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.